AR075900A1 - Metodos para la preparacion de acidos (2-(8,9-dioxo-2,6-diazabiciclico (5.2.0) non-1(7)-en-2-il)etil) fosfonico y sus precursores. - Google Patents
Metodos para la preparacion de acidos (2-(8,9-dioxo-2,6-diazabiciclico (5.2.0) non-1(7)-en-2-il)etil) fosfonico y sus precursores.Info
- Publication number
- AR075900A1 AR075900A1 ARP100100895A ARP100100895A AR075900A1 AR 075900 A1 AR075900 A1 AR 075900A1 AR P100100895 A ARP100100895 A AR P100100895A AR P100100895 A ARP100100895 A AR P100100895A AR 075900 A1 AR075900 A1 AR 075900A1
- Authority
- AR
- Argentina
- Prior art keywords
- dioxo
- phosphonic
- acid
- diazabicyclo
- ethyl
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- 150000007513 acids Chemical class 0.000 title 1
- 239000002243 precursor Substances 0.000 title 1
- 150000002148 esters Chemical class 0.000 abstract 5
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 abstract 4
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 abstract 3
- -1 8,9-dioxo-2,6 -diazabicyclo [5.2.0] non-1 (7) -en-2-yl Chemical group 0.000 abstract 2
- BDABGOLMYNHHTR-UHFFFAOYSA-N Perzinfotel Chemical compound OP(O)(=O)CCN1CCCNC2=C1C(=O)C2=O BDABGOLMYNHHTR-UHFFFAOYSA-N 0.000 abstract 2
- ZTWTYVWXUKTLCP-UHFFFAOYSA-L ethenyl-dioxido-oxo-$l^{5}-phosphane Chemical compound [O-]P([O-])(=O)C=C ZTWTYVWXUKTLCP-UHFFFAOYSA-L 0.000 abstract 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 2
- 239000000010 aprotic solvent Substances 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Reivindicacion 1: Un proceso para la preparacion de ácido [2-(8,9-dioxo-2,6-diazabiciclo[5.2.0]non-1(7)-en-2-il)etil]fosfonico, que comprende: hacer reaccionar 1,3-diaminopropano con dialquilvinilfosfonato para formar éster dialquílico del ácido N-(3-aminopropil)aminoetanfosfonico; hacer reaccionar el éster dialquílico del ácido N-(3-aminopropil)aminoetanfosfonico con 3,4-dialcoxi-3-ciclobuten-1,2-diona para formar éster dialquílico del ácido [2-(8,9-dioxo-2,6-diazabiciclo[5.2.0]non-1(7)-en-2-il)etil]fosfonico; e hidrolizar el éster dialquílico del ácido [2-(8,9-dioxo-2,6-diazabiciclo[5.2.0]non-1(7)-en-2-il)etil]fosfonico para formar el ácido [2-(8,9-dioxo-2,6-diazabiciclo[5.2.0]non-1(7)-en-2-il)etil]fosfonico; con la condicion de que (a) el paso de reaccion de 1,3-diaminopropano con dialquilvinilfosfonato se lleve a cabo sustancialmente en ausencia de solvente exogeno; y/o (b) el paso de reaccion del éster dialquílico del ácido N-(3-aminopropil)aminoetanfosfonico con 3,4-dialcoxi-3-ciclobuten-1,2-diona se lleve a cabo en un solvente aprotico.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16151309P | 2009-03-19 | 2009-03-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR075900A1 true AR075900A1 (es) | 2011-05-04 |
Family
ID=42227623
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP100100895A AR075900A1 (es) | 2009-03-19 | 2010-03-19 | Metodos para la preparacion de acidos (2-(8,9-dioxo-2,6-diazabiciclico (5.2.0) non-1(7)-en-2-il)etil) fosfonico y sus precursores. |
Country Status (12)
Country | Link |
---|---|
US (2) | US20120116074A1 (es) |
EP (1) | EP2408790A1 (es) |
JP (1) | JP2012521352A (es) |
KR (1) | KR20110139274A (es) |
CN (1) | CN102356087A (es) |
AR (1) | AR075900A1 (es) |
AU (1) | AU2010226479A1 (es) |
BR (1) | BRPI1009900A2 (es) |
CA (1) | CA2754390A1 (es) |
MX (1) | MX2011009716A (es) |
WO (1) | WO2010108063A1 (es) |
ZA (1) | ZA201107412B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101960330B (zh) * | 2008-02-25 | 2013-12-04 | 皇家飞利浦电子股份有限公司 | 用于辐射探测器的等平面主链 |
WO2010121133A2 (en) * | 2009-04-17 | 2010-10-21 | The General Hospital Corporation | Multimodal imaging of fibrin |
KR101474063B1 (ko) | 2012-05-23 | 2014-12-19 | 동국대학교 산학협력단 | 피브린 표적 펩타이드 서열이 결합된 글라이콜 키토산-금 나노입자를 포함하는 혈전 탐지용 ct 조영제 |
CN105939732A (zh) * | 2013-12-03 | 2016-09-14 | 通用医疗公司 | 分子成像探针 |
US10093741B1 (en) | 2017-05-05 | 2018-10-09 | Fusion Pharmaceuticals Inc. | IGF-1R monoclonal antibodies and uses thereof |
CA3062553C (en) | 2017-05-05 | 2024-02-06 | Fusion Pharmaceuticals Inc. | Pharmacokinetic enhancements of bifunctional chelates and uses thereof |
AU2018261890A1 (en) | 2017-05-05 | 2019-11-28 | Centre For Probe Development And Commercialization | IGF-1R monoclonal antibodies and uses thereof |
EP4072425A4 (en) * | 2019-12-09 | 2023-08-23 | Sino Canada Health Institute Inc. | METHOD FOR MONITORING PET READ POSITIONS USING MRI MARKERS |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH584232A5 (es) * | 1973-07-26 | 1977-01-31 | Ciba Geigy Ag | |
US4899755A (en) | 1985-05-08 | 1990-02-13 | The General Hospital Corporation | Hepatobiliary NMR contrast agents |
US5021556A (en) | 1987-07-22 | 1991-06-04 | Neorx Corporation | Method of radiolabeling chelating compounds comprising sulfur atoms with metal radionuclides |
US5075099A (en) | 1988-05-31 | 1991-12-24 | Neorx Corporation | Metal radionuclide chelating compounds for improved chelation kinetics |
US5364613A (en) | 1989-04-07 | 1994-11-15 | Sieving Paul F | Polychelants containing macrocyclic chelant moieties |
CA2065290C (en) | 1989-08-28 | 2000-12-12 | Randall B. Lauffer | Hydroxy-aryl metal chelates for diagnostic nmr imaging |
US5367080A (en) | 1990-11-08 | 1994-11-22 | Sterling Winthrop Inc. | Complexing agents and targeting radioactive immunoreagents useful in therapeutic and diagnostic imaging compositions and methods |
US5168103A (en) * | 1991-01-22 | 1992-12-01 | American Home Products Corporation | [[2-(amino-3,4-dioxo-1-cyclobuten-1-yl) amino]alkyl]-acid derivatives |
US5849261A (en) | 1991-02-08 | 1998-12-15 | Diatide, Inc. | Radiolabeled vasoactive intestinal peptides for diagnosis and therapy |
US5965107A (en) | 1992-03-13 | 1999-10-12 | Diatide, Inc. | Technetium-99m labeled peptides for imaging |
EP0570493B1 (en) | 1991-02-08 | 2000-01-05 | Diatide, Inc. | TECHNETIUM-99m LABELED POLYPEPTIDES FOR IMAGING |
WO1995025119A1 (en) | 1994-03-16 | 1995-09-21 | Mallinckrodt Medical, Inc. | Stabilization of peptides and proteins for radiopharmaceutical use |
US5582814A (en) | 1994-04-15 | 1996-12-10 | Metasyn, Inc. | 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging |
TW319763B (es) | 1995-02-01 | 1997-11-11 | Epix Medical Inc | |
US5672877A (en) | 1996-03-27 | 1997-09-30 | Adac Laboratories | Coregistration of multi-modality data in a medical imaging system |
DK0907379T3 (da) | 1996-04-01 | 2004-08-16 | Epix Medical Inc | Bioaktiveret diagnostisk billeddannelseskontrastmiddel |
ES2257771T3 (es) | 1996-10-28 | 2006-08-01 | Amersham Health As | Agentes de contraste. |
US5919967A (en) | 1997-04-11 | 1999-07-06 | Epix Medical, Inc. | Process for synthesizing phosphodiesters |
US5886142A (en) | 1997-05-20 | 1999-03-23 | Thomas Jefferson University | Radiolabeled thrombus imaging agents |
EP1000072B1 (en) * | 1997-08-01 | 2003-02-19 | Wyeth | Process for the preparation of [2-((8,9)- dioxo-2,6-diazabicyclo [5.2.0]-non-1(7)-en-2-yl)-ethyl] phosphonic acid |
ES2206996T3 (es) | 1997-10-02 | 2004-05-16 | Epix Medical Inc | Metodo de formacion de imagenes para diagnostico con contraste mejorado para monitorizar terapias de intervencion. |
AU768859B2 (en) | 1999-07-29 | 2004-01-08 | Dyax Corp. | Binding moieties for fibrin |
US6984373B2 (en) | 2000-12-23 | 2006-01-10 | Dyax Corp. | Fibrin binding moieties useful as imaging agents |
US6549798B2 (en) | 2001-02-07 | 2003-04-15 | Epix Medical, Inc. | Magnetic resonance angiography data |
TWI221406B (en) | 2001-07-30 | 2004-10-01 | Epix Medical Inc | Systems and methods for targeted magnetic resonance imaging of the vascular system |
TWI284539B (en) | 2001-07-30 | 2007-08-01 | Epix Pharm Inc | A method for making a magnetic resonance (MR) imaging agent, a MR imaging contrast agent, a method for altering stability of a peptide and a modified peptide |
DE10141186A1 (de) | 2001-08-22 | 2003-03-20 | Siemens Ag | Einrichtung zum Bearbeiten von Bildern, insbesondere medizinischen Bildern |
UA78529C2 (en) | 2001-10-10 | 2007-04-10 | Wyeth Corp | Derivatives of [[2-(amino-3,4-dioxo-1-cyclobutene-1-yl)amino]alkyl] acid for treating pain |
US6898331B2 (en) | 2002-08-28 | 2005-05-24 | Bae Systems Aircraft Controls, Inc. | Image fusion system and method |
WO2005001415A2 (en) * | 2003-05-23 | 2005-01-06 | Epix Pharmaceuticals, Inc. | Optically pure and enriched isomers of chelating ligands and contrast agents |
CA2783275A1 (en) | 2003-07-24 | 2005-02-03 | Bracco Imaging S.P.A. | Stable radiopharmaceutical compositions and methods for their preparation |
TW200514775A (en) * | 2003-10-22 | 2005-05-01 | Wyeth Corp | Methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof |
WO2007047608A2 (en) | 2005-10-14 | 2007-04-26 | Epix Pharmaceuticals, Inc. | Fibrin targeted therapeutics |
JP5364589B2 (ja) * | 2006-12-11 | 2013-12-11 | ブラッコ・イメージング・ソシエタ・ペル・アチオニ | 診断および治療適用用フィブリン結合ペプチドコンジュゲート |
JP2010537999A (ja) * | 2007-08-27 | 2010-12-09 | ワイス・エルエルシー | 麻酔薬節約効果を得るためのnmda拮抗薬を用いる組成物および方法 |
-
2010
- 2010-03-19 CN CN2010800119434A patent/CN102356087A/zh active Pending
- 2010-03-19 AR ARP100100895A patent/AR075900A1/es not_active Application Discontinuation
- 2010-03-19 BR BRPI1009900A patent/BRPI1009900A2/pt not_active Application Discontinuation
- 2010-03-19 AU AU2010226479A patent/AU2010226479A1/en not_active Abandoned
- 2010-03-19 US US13/256,777 patent/US20120116074A1/en not_active Abandoned
- 2010-03-19 KR KR1020117024351A patent/KR20110139274A/ko not_active Application Discontinuation
- 2010-03-19 CA CA2754390A patent/CA2754390A1/en not_active Abandoned
- 2010-03-19 WO PCT/US2010/027908 patent/WO2010108063A1/en active Application Filing
- 2010-03-19 EP EP10710739A patent/EP2408790A1/en not_active Withdrawn
- 2010-03-19 MX MX2011009716A patent/MX2011009716A/es not_active Application Discontinuation
- 2010-03-19 JP JP2012500984A patent/JP2012521352A/ja not_active Withdrawn
- 2010-04-16 US US13/256,795 patent/US9200017B2/en active Active
-
2011
- 2011-10-10 ZA ZA2011/07412A patent/ZA201107412B/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2012521352A (ja) | 2012-09-13 |
EP2408790A1 (en) | 2012-01-25 |
MX2011009716A (es) | 2011-10-17 |
CA2754390A1 (en) | 2010-09-23 |
AU2010226479A1 (en) | 2011-09-22 |
US20120077958A1 (en) | 2012-03-29 |
ZA201107412B (en) | 2012-07-25 |
KR20110139274A (ko) | 2011-12-28 |
BRPI1009900A2 (pt) | 2016-03-15 |
CN102356087A (zh) | 2012-02-15 |
WO2010108063A1 (en) | 2010-09-23 |
US9200017B2 (en) | 2015-12-01 |
US20120116074A1 (en) | 2012-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR075900A1 (es) | Metodos para la preparacion de acidos (2-(8,9-dioxo-2,6-diazabiciclico (5.2.0) non-1(7)-en-2-il)etil) fosfonico y sus precursores. | |
IN2015DN00909A (es) | ||
TW200942513A (en) | Process for the preparation of fatty acid alkyl esters | |
BR122016016465B8 (pt) | Concentrados estáveis emulsificáveis contendo um primeiro sal do ácido carboxílico herbicida e um segundo éster do ácido carboxílico herbicida, e método para sua preparação | |
ATE512994T1 (de) | Hocheffizientes verfahren zur herstellung von polyalkylenoxidcarbonsäuren | |
AR072580A1 (es) | Procedimiento para la obtencion de esteres de acido pirazolcarboxilicos disustituidos en 1,3 | |
CL2011000296A1 (es) | Proceso de preparación del ester metílico del ácido 4-oxo-octahidro-indol-1-carboxílico y compuestos intermediarios utilizados. | |
AU2009310099A8 (en) | Agricultural compositions | |
BR112013017101A2 (pt) | uso de ésteres de ácido poliisobutenosucínico com um álcool, hidrogel, processo para produzir um hidrogel, e, uso de um hidrogel | |
BR112013030145A2 (pt) | processo para preparação de ácido metacrílico | |
MY159883A (en) | Production of ethylenically unsaturated acids or esters thereof | |
BR112014032741A2 (pt) | lipase em esterificação de ácidos graxos de cadeia curta | |
WO2015050656A3 (en) | Methods and industrial processes for the generation of free fatty acids derivatives thereof from oil gums | |
ES2555139T3 (es) | Nuevo procedimiento para la preparación de Linezolid y sus nuevos intermedios | |
CY1114493T1 (el) | Διαδικασια για την παρασκευη μιας ενωσης χρησιμης ως αναστολεα της tafia | |
WO2014193652A3 (en) | Novel n-3 immunoresolvents: structures and actions | |
MX2019008652A (es) | Metodos mejorados para la acilacion del maitansinol. | |
EA201300440A1 (ru) | Способ получения (3s,3s') 4,4'-дисульфандиилбис(3-аминобутан-1-сульфокислоты) | |
MX2010009926A (es) | Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico. | |
MX2010006995A (es) | 3-n-fenil-1,3,4-oxadiazolonas sustituidas con 5-o para uso medico. | |
DK2121950T3 (da) | Fremgangsmåde til kemoselektiv enzymatisk hydrolyse af en diester-sammensætning til fremstilling af en monoester-monosyre-sammensætning | |
PA8799601A1 (es) | Proceso para sintetizar compuestos de acido fosfonico y fosfinico | |
AR092613A1 (es) | Proceso de produccion de lactato | |
ES2571437T3 (es) | Proceso en un solo reactor para preparar pemetrexed disódico | |
Tsapleva et al. | Synthesis of diglycerides containing polyunsaturated fatty acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |